BridgeMD
New treatment option for Coronary Heart Disease
Official title Project 3: ACHIEVE- CHD
ClinicalTrials.gov ID: NCT05918380
What this study is testing
- What it's testing
- This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region) Center (IRB 100221MP2A), the purpose of which is to reduce cardiometabolic health disparities and downstream Black-White lifespan inequality in two cities: Detroit, Michigan, and Cleveland, Ohio. The ACHIEVE GREATER Center will involve three separate but related projects that aim to mitigate health disparities in risk factor control for three chronic conditions, hypertension (HTN, Project 1), heart failure (HF, Project 2) and coronary heart disease (CHD, Project 3), which drive downstream lifespan inequality.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 75
You may be able to join if
- 40 to 75 years of age
- Self-identified as Black or African American
- Residence in the Cleveland Metro Area
- Must have at least two of the following risk factors identified at a UH health fair screenings, with one risk factor being with SBP, A1c, or LDL:
- BMI≥30 mg/dL
You likely can't join if
- Established documented cardiovascular disease (coronary artery disease, peripheral artery disease, myocardial infarction, stroke).
- Systolic blood pressure ≥ 180 mmHg or diastolic blood pressure ≥ 110 mmHg
- Lung disease requiring supplemental oxygen therapy
- Individuals receiving treatment for cancer related disease
- Pregnant or nursing mothers
See the full eligibility criteria
- 40 to 75 years of age
- Self-identified as Black or African American
- Residence in the Cleveland Metro Area
- Must have at least two of the following risk factors identified at a UH health fair screenings, with one risk factor being with SBP, A1c, or LDL:
- BMI≥30 mg/dL
- History of smoking
- Elevated blood pressure defined as SBP\>140 or DBP\>80 mmHg
- HbA1c≥5.7%
- LDL≥130
- Able to complete a coronary artery calcium score test (CAC)
- Willing and able to consent
- Willing to have a UH provider and UH care
- Currently insured for standard of care procedures
- Established documented cardiovascular disease (coronary artery disease, peripheral artery disease, myocardial infarction, stroke).
- Systolic blood pressure ≥ 180 mmHg or diastolic blood pressure ≥ 110 mmHg
- Lung disease requiring supplemental oxygen therapy
- Individuals receiving treatment for cancer related disease
- Pregnant or nursing mothers
The study team makes the final eligibility decision.
Where it's taking place
- Cleveland, Ohio, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cleveland, Ohio, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.